Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics. This is achieved by applying a rapid and consistent approach to specifically modifying recombinant proteins, and has broad utility in developing improved therapeutic proteins including monoclonal antibodies.
Cobra Therapeutics was founded as Therexsys in 1992 with the intention of developing a company dedicated to gene therapy based on locus control region technology and non-viral gene delivery. The Company changed its name in 1998 following acquisition of Cobra Biosciences, a start-up company founded by scientists at Birmingham and Aston Universities and focused on the use of adenoviral delivery vectors for cancer gene therapy. Today this gives Cobra a leading position in both viral and non-viral gene delivery technologies.
Medgenics, Inc. is a holding company with one wholly owned subsidiary Medgenics Medical Israel Ltd. (formerly Biogenics Ltd.). The Company and its subsidiary are engaged in the research and development of products in the field of biotechnology and associated medical equipment. The Company is considered as a development-stage company. The Company is developing an approach to treating chronic diseases, using a platform technology, a biological Biopump, enabling patients to produce their own natural human protein therapy. The Biopump technology is made from the patient’s own skin and is implanted in a procedure to work inside the patient’s body, to produce and deliver the active protein steadily over a sustained period to treat the targeted disease. The Company has completed the design, fabrication and evaluation of the key devices required for harvesting patient micro-organs and implanting Biopumps, including EPODURE, back into patients. (Source: ARS)
AdproTech, based in Royston, U.K., was founded in 1997 and aims to be the leading company in advanced protein engineering for drug development. The drug development programme focuses on the adaptation of complement inhibitors for potential therapeutic use in the treatment of inflammatory disorders such as stroke and arthritis.
enGene Inc. is a privately held biotechnology company developing a proprietary technology that offers a unique therapeutic solution to treating metabolic diseases such as diabetes and obesity as well as other diseases caused by protein insufficiency. Our initial product, GEMS(TM) for diabetes (GEMS(TM)-insulin), is in the pre-clinical phase. GEMS(TM) for obesity is in the discovery phase, as is GEMS(TM) for hemophilia. enGene holds broad and exclusive patent protection for its technologies.
GenOdyssee is a drug discovery company using a unique, IP-protected approach to discovery of superior protein products. GenOdyssee discovers natural variants of proteins with higher efficacy and safety than marketed versions of the same therapeutic proteins. This approach is ideal for discovery of ‘next generation' protein products for already-developed blockbuster markets. The company has a proprietary genomic DNA databank representative of the human population, which is screened for natural genetic variants of therapeutic proteins with superior properties. This approach to drug discovery is based on the idea that natural evolution may have lead to the generation in the current population of unpredictable mutations that would confer superior therapeutic status to known human therapeutic proteins.
QSV Biologics, Ltd. is a North American based cGMP biologics contract manufacturer providing mammalian cell culture, microbial fermentation and purification services for the production of protein therapeutics, monoclonal antibodies, vaccines and diagnostics. Our facility has a 10 year track record and is licensed for cGMP manufacture of pre-clinical, clinical and commercial supply. QSV recently underwent a comprehensive GMP compliance audit by Health Canada's Health Products and Food Branch Inspectorate (HPFBI) and was found to be compliant with all applicable regulations and guidelines. QSV's market consists of Canadian, U.S., Australian, Asian and European biotechnology firms with protein therapeutics in development. As a dedicated biopharmaceutical contract manufacturer, QSV provides the following services: cGMP Microbial Fermentation Microbial Process Development Upstream and Downstream Mammalian Cell Culture Process Development Upstream and Downstream cGMP Cell Bank Development & Storage Analytical Development Process & Analytical Validation Process Scale Up cGMP Document Services Technology Transfer Quality is your first consideration when selecting a contract manufacturer. Quality is our first priority! More information can be obtained by contacting: Richard Hetrick Business Development Phone: (484) 678 - 4820 Phone: (780) 438 - 7143 Fax: (610) 873 - 8453 Email: rhetrick@qsvbiologics.com
Viron Therapeutics is a clinical stage biopharmaceutical company developing a completely new class of anti-inflammatory therapeutics to treat and prevent human inflammatory disorders. Viron's novel approach to drug development is based on the use of viral proteins as a source of therapeutic products. By harnessing the evolutionary power of viruses to withstand the human body's protective inflammatory response, Viron is able to identify and develop powerful protein therapeutics that have distinct advantages in potency and efficacy over conventional drug therapy. The Company's lead compound, VT-111, is currently in a Phase II clinical trial for the treatment of vascular inflammation in patients with Acute Coronary Syndromes and will soon submit an IND for its second indication, the prevention of chronic organ rejection in transplant patients. Viron's pipeline of additional compounds in preclinical development, combined with a robust discovery program, strongly positions the Company to be a leader in the discovery and commercialization of bio-therapeutics to treat inflammatory based diseases.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory